Work Here?
Work Here?
Work Here?
Corcept Therapeutics focuses on developing treatments that regulate cortisol levels in the body, which is important for managing various health issues. Their main product, Korlym, is used to treat Cushing's syndrome, a condition caused by too much cortisol. Korlym was approved by the FDA in 2012 and is the first medication specifically for this disorder. Corcept stands out from competitors by having a strong emphasis on research and development, having discovered over 1,000 unique cortisol modulators. The company aims to expand its range of treatments while also providing educational resources to healthcare professionals and patients to improve understanding and care for cortisol-related conditions.
Company Stage
IPO
Employees
201-500
Industries
Hardware, Biotechnology
Total Funding
$119.1M
Headquarters
N/A
Founded
1998
Find jobs on Simplify and start your career today